Watch: How does Gilead’s experimental drug remdesivir work against the coronavirus?
Gilead Sciences’ experimental drug remdesivir has been gaining traction as a potential Covid-19 treatment, and late last week scored an emergency use authorization from federal regulators for it to be used in patients with the condition.
Preliminary data released last week from a closely watched trial run by the National Institute of Allergy and Infectious Diseases showed that Covid-19 patients who were given remdesivir recovered faster than those who received a placebo.
